Clinical Trials Browser

NETWORK × Carcinoma, Non-Small-Cell Lung × 90 days × Clear all

NCT06931717 2026-03-18

ARCH

Phase 3 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT06284317 2026-03-16

ADOPT-lung

Phase 3 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT06686771 2026-03-05

CURB2

Phase 3 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT06219317 2026-02-23

ICARS

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT03965468 2026-02-09

CHESS

Phase 2 Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT07393555 2026-02-06

Treatment for Advanced Non-small Cell Lung Cancer With Actionable Genomic Alterations After Targeted Treatment and Chemotherapy (An Expanded Lung-MAP Treatment Trial)

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06031688 2026-01-23

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05601973 2026-01-21

AMAZE-lung

Phase 2 Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT05673187 2026-01-21

ADEPPT

Phase 2 Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT07347977 2026-01-16

LidCRM

Phase NA Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Recurrence

NCT02201992 2025-12-19

Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)

Phase 3 Active not recruiting

Carcinoma, Non-Small-Cell Lung